Mohanram Narayanan MD, FACP, FASN, FNKF,FRCP (C) Reference List Abstract

Size: px

Start display at page:

Download "Mohanram Narayanan MD, FACP, FASN, FNKF,FRCP (C) Reference List Abstract"

Caitlin Ryan
6 years ago
Views:

1 Abstract Primary Hyperoxaluria Causing ESRD and Lower Extremity Gangrene 662 Nidhi Munshi, Mohanram Narayanan 66E Abstract and Poster presented at the Annual Dialysis Conference March, Orlando, FL Effect of Hepatitis C infection on anemia in hemodialysis patients 772 Anand Khurana, Mohanram Narayanan, Allan E Nickel 662Abstract presented at the Spring Clinical Meeting of the National Kidney Foundation, April, Orlando, FL Statin Use Improves Survival Post Kidney Transplantation 626 Judson Severson, Luis Concepcion, Mohanram Narayanan 626 Abstract presented at the 40th Annual Meeting of the American Society of Nephrology, Nov. San Francisco, CA (SAPO443) 2007 Post transplant anemia: A single center experience 626 Anand Khurana, Mohanram Narayanan 66E Abstract presented at the Annual Meeting of the Texas Transplantation Society, July, San Antonio, TX Retrospective Evaluation and Characterization of Health Care Utilization in a Managed Care Organization for Members with Stage 1, 2, or 3 Chronic Kidney Disease 66E Tonya Martin, Charles Foulks, Barry Browne, Mohanram Narayanan 626 Abstract presented at the 39th Annual Meeting of the American Society of Nephrology, Nov. San Diego, CA (SA-PO337) 2006 Incidence & Risk Factors for Development of Post Transplant Diabetes Mellitus in Renal Allograft Recipients 727 a single center experience 662 Nidhi Munshi, Mohanram Narayanan - Poster and Podium presentation at 99th Annual Scientific Assembly of Southern Medical Association, Nov, San Antonio, TX May 21,

2 Abstract Improvement of Bone Density with Alendronate after Renal Transplantation 662 Elena Slavcheva, Charles McCuskey, Mohanram Narayanan, Gregory Jaffers et al 662 Abstract presented at the 3rd American Transplant Congress, May, Washington, D.C Treatment of CMV Infection in Renal Transplant Recipients with an Abbreviated Course of IV Ganciclovir - Elena Slavcheva, Gregory Jaffers, Mohanram Narayanan et al 26E Abstract presented at the 35th Annual Meeting of the American Society of Nephrology, Nov., Philadelphia, PA. (SU-P0470) 2002 Book Chapter Narayanan M, Watson RE, DiPette DJ: Hypertension: Evaluation, Therapy & Review of Landmark Trials. In Abela GS, ed. Peripheral Vascular Disease: Basic Diagnostic & Therapeutic Approaches. Philadelphia: Lippincott, Williams & Wilkins, Clark LJ, Kanarvogel L, Narayanan M, Runde M, Smith GA: Internal Medicine Practice Questions Book 1, Vol 1&2 Ed Burday MJ; Medtext Medical Publishing Co. Redondo Beach, CA 1996 Bloom R, Bromberg J, Poggio E, Bunnapradist S, Langone A, Sood P, Matas A, Mehta S, Sharfuddin A, Fischbach B, Narayanan M, et al: Cell-free DNA and Active Rejection in Kidney Allografts. Journal of the American Society of Nephrology. Epub ahead of print March 9, Bromberg J, Brennan D, Poggio E, Suphamai B, Langone A, Sood P, Matas A, Mehta S, Sharfuddin A, Fischbach B, Narayanan M, et al: Biological Variation of Donor-derived Cell-free DNA in Renal Transplant Recipients: Clinical Implications. Journal of Applied Laboratory Medicine, Sept May 21,

3 Pakanati A, Padooru K, Narayanan M: Role of Cinacalcet in Management of Post Renal Transplant Residual Hyperparathyroidism and Hypercalcemia - Retrospective Chart Review. American Journal of Kidney Disease 2015;65(4):A Narayanan M, Pankewycz O, Shihab F, Wiland A, Mccague K, Chan L: Long-term Outcomes in African American Kidney Transplant Recipients under Contemporary Immunosuppression: a Four-Year Analysis of the Mycophenolic Acid Observational REnal Transplant (MORE) Study. Clinical Transplantation 2014;28-(2): Hatahet M, Narayanan M, Cleaves C, Zreik R: Disseminated Mucormycosis in a Patient with Recent Kidney Transplantation: Case Report and Literature Review. Case Rep Nephrol Urol 2013 May 7;3 (1): Langone A, Doria C, Greenstein S, Narayanan M, Ueda K, Sankari B, Pankewycz O, Shihab F, Chan L: Does Reduction of Mycophenolic Acid Dose Compromise Efficacy Regardless of Tacrolimus Exposure Level? An Analysis of Prospective Data from the Mycophenolic Renal Transplant (MORE) Registry. Clinical Transplantation 2013;27(1): Narayanan M, Pankewycz O, El-Ghoroury M, Shihab F, Wiland A, Mccague K, Chan L: Outcomes in African American Kidney Transplant Patients Receiving Tacrolimus and Mycophenolic Acid Immunosuppression. Transplantation 2013;95(4): Doria C, Greenstein S, Narayanan M, Ueda K, Wiland A, McCague K, Sankari B, Chan L: Associationi of Mycophenolic Acid Dose with Efficacy and Safety Events in Kidney Transplant Patients Receiving Tacrolimus: an Analysis of the Mycophenolic Acid Observational Renal Transplant Registry. Clinical Transplantation 2012;26(6):E602- E May 21,

4 Jaffers G, Narayanan M, Fasola C: Surgical Correction of Nephrogenic Ascites in a Renal Transplant Recipient. Experimental and Clinical Transplantation 2012;4: Narayanan M, Pankewycz O, Shihab F, Wiland A, Mccague K, Chan L: Immunosuppession and Outcomes in African American (AA) Renal Transplant Recipients: A 4-year Analysis from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. Journal of the American Society of Nephrology Nov. 2012;23:855A-856A 2012 Narayanan M, Pankewycz O, Shihab F, Wiland A, Mccague K, Chan L: Two-Year Outcomes of African American (AA) Renal Transplant Recipients from the Mycophenolic Acid Observational Renal Transplant (MORE) Reistry. American Journal of Transplantation May 2012; Supp 3;12: Seerangan G, Narayanan M: A Rare Case of Subarachnoid Hemorrhage due to Rupture of Isolated Anterior Spinal Artery Aneurysm in a Patient with Polycystic Kidney Disease. Case Rep Nephrol Urol 2012;2: Narayanan M, Pankewycz O, El-Ghoroury M, Shihab F, Wiland A, Mccague K, Chan L: African American (AA) Renal Transplant One Year Outcomes from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. Journal of the American Society of Nephrology Nov 2011;22:342A 2011 Narayanan M, Pankewycz O, et al: Enteric-Coated Mycophenolate Sodium (EC-MPS) versus Mycophenolate Mofetil (MMF) in African American (AA) Renal Transplant Recipients from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. Amer J of Transplantation Apr 2011;Supp 2;11: May 21,

5 Shihab F, Chan L, Narayanan M, et al: Early Outcome Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry: Comparisons of Enteric-Coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Patients with Diabetes Mellitus (DM) prior to Transplant. Amer J of Transplantation Apr 2011;Supp 2;11: Chan L, Irish W, Doria C, Greenstein S, Narayanan M, et al: Distinct Effects of Delayed Graft Function (DGF) and Acute Rejection (BPAR) on Graft Failure (GF) following Kidney Transplantation (KTx): Analysis of the Mycophenolic Acid (MPA) Observational Renal Transplant (MORE) Registry. Amer J of Transplantation May 2010;Supp 4;10: Goraya N, Narayanan M: Prediction of Cardiovascular Disease during Pre-Transplant Evaluation. J of Amer Society of Nephrology, Nov 2010;21:329A 2010 Irish W, Doria C, Greenstein S, Chan L, Narayanan M, et al: Durable Dosing Patterns of Mycophenolic Acid (MPA) in Renal Transplantation: Initial Outcome Analysis of the Mycophenolic Acid (MPA) Observational Renal Transplant (MORE) Registry. Amer J of Transplantation May 2010;Supp 4;10: Langone A, Irish W, Doria C, Greenstein S, Narayanan M, et al: Real- World Calcineurin Inhibitor (CNI) Minimization Strategies: Outcomes Analysis of the Mycophenolic Acid (MPA) Renal Transplant (MORE) Registry. Amer J of Transplantation May 2010;Supp 4;10: Narayanan M, Pankewycz O, et al: Enteric-Coated Mycophenolate Sodium (EC-MPS) Versus Mycophenolate Mofetil (MMF) in African American (AA) Renal Transplant Recipients from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. J of Amer Society of Nephrology Nov 2010;21:325A 2010 May 21,

6 Shihab F, Chan L, Narayanan M, et al: Comparisons of Enteric-Coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Recipients (RTRS) with Diabetes Mellitus (DM) prior to Transplant in the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. J of Amer Society of Nephrology, Nov 2010;21:969A 2010 Goraya N, Narayanan M, Jaffers G: Biopsy Proven BK Polyoma Nephropathy in the Presence of Viruria and Lack of Viremia. American Journal of Transplantation. May 2009;Supp 2;9: Irish W, Greenstein S, Doria C, Chan L, Narayanan M, et al: The Mycophenologic Acid Observational Renal Transplant Study (MORE) Registry: Summary of Patient Management in De Novo Renal Transplantation. Amer Journal of Transplantation, May 2009;Supp 2;9: Irish W, Doria C, Greenstein S, Chan L, Narayanan M, et al. Mycophenolic Acid (MPA) in Diabetic Kidney Transplant Patients: An Analysis of the MORE Registry. Journal of the Amer Soc of Nephrology, Oct 2009;20:885A-886A 2009 Irish W, Doria C, Greenstein S, Chan L, Narayanan M, et al: Mycophenolic Acid (MPA) Therapy in Kidney Transplantation: An Analysis of the MORE Registry. Journal of the Amer Society of Nephrology Oct 2009;20:573A 2009 Mahajan A, Narayanan M, Concepcion L, Jaffers G: Hypoparathyroidism Associated with Severe Mineral Bone Disease Post Renal Transplantation, Treated Successfully with Recombinant PTH. Hemodialysis International 2009;13(4): May 21,

7 Mahajan A, Narayanan M, Jaffers G: Atypical Presentation of Cytomegalovirus Colitis in Renal Allograft Recipients. Journal of the Amer Soc of Nephrology Oct 2009;20:897A-898A 2009 Munshi N, Concepcion L, Narayanan M: Primary Hyperoxaluria Causing ESRD and Gangrene of Extremities Leading to Amputations. Hemodialysis International 2009;13(3): Khurana A, Nickel A, Greene Jr. J, Narayanan M, High W, Foulks C: Successful Pregnancy in a Hemodialysis Patient and Marked Resolution of Her Nephrogenic Systemic Fibrosis. American Journal of Kidney Disease; 51 (6): e29-e Khurana A, Nickel A, Narayanan M, Foulks C: Effect of Hepatitis C Infection on Anemia in Hemodialysis Patients. Hemodialysis International; 12 (1): Mahajan A, Concepcion L, Narayanan M: Elemental My Dear Watson. Journal of the American Society of Nephrology, Oct 2008;19:939A 2008 Mahajan A, Narayanan M, Song J: Determinants of Immune Function in Renal Transplant Patients. Journal of the American Society of Nephrology, Oct 2008;19:446A 2008 May 21,

8 Munshi N, Concepcion L, Narayanan M: Primary Hyperoxaluria Causing ESRD and Lower Extremity Gangrene. Hemodialysis International; 12 (2): Khurana A, Runge V, Narayanan M, Greene Jr. J, Nickel A: Nephrogenic Systemic Fibrosis: A Review of Six Cases Temporally Related to Gadodiamide Injection (Omniscan). Investigative Radiology Feb.; 42 (2): Narayanan M, Szymanski J, Slavcheva E, Rao A, Kelly A, Jones K, Jaffers G: BK Virus Associated Renal Cell Carcinoma: Case Presentation with Optimized PCR and Other Diagnostic Tests. American Journal of Transplantation; 7 (6): Severson J, Concepcion L, Narayanan, M: Risk factors for BK Virus Infection. Journal of the American Society of Nephrology October; 18: 884A 2007 Severson J, Concepcion L, Narayanan, M: Statin Use Improves Survival Post Kidney Transplantation. Journal of the American Society of Nephrology October; 18: 438A 2007 Khurana A, Foulks, C, Narayanan, M: Post Transplant Anemia: A Single Center Experience. Journal of the American Society of Nephrology November; 17: 860A 2006 May 21,

9 Martin T, Foulks C, Browne B, Narayanan, M: Retrospective Evaluation and Characterization of Health Care Utilization in a Managed Care Organization for Members with Stage 1, 2, or 3 Chronic Kidney Disease. Journal of the American Society of Nephrology November; 17: 646A 2006 Munshi N, Narayanan M: Incidence and Risk Factors for Development of Post Transplant Diabetes Mellitus in Renal Allograft Recipients: A Single-Center Experience. Southern Medical Journal October; 98(10): S Narayanan M, Slavcheva E, Rao A, Jones K, Jaffers G: Renal Cell Carcinoma Following BK Virus & SV40 Co-Infection in Polyomavirus Nephropathy. Journal of the American Society of Nephrology October; 15: 869A 2004 Slavcheva E, McCuskey C, Harris D, Narayanan M, Jaffers G: Outcomes of Renal Allograft Biopsy under Direct Ultrasonographic Visualization. Journal of the American Society of Nephrology October; 15: 887A 2004 Slavcheva E, McCuskey C, Fisher M, Atkins M, Narayanan M, Jaffers G: Improvement of Bone Density with Alendronate after Renal Transplantation. American Journal of Transplantation June; Supplement 5; 3: 244A 2003 Slavcheva E, Jaffers G, Narayanan M, Moore C, McCuskey C, Carpenter C: Treatment of CMV Infection in Renal Transplant Recipients with an Abbreviated Course of IV Ganciclovir. Journal of the American Society of Nephrology September; 13: 564A 2002 May 21,

10 Alberto G, Erickson T, Popiel R, Narayanan M, Hryhorczuk D: Central Nervous System Manifestations of a Valproic Acid Overdose Responsive to Naloxone. Annals of Emergency Medicine; 18 (8): Submitted or in Preparation Martin TM, Browne BA, Foulks CJ, Narayanan M, Powell K. Health care utilization in a managed care setting for members with Stage 1, 2 or 3 chronic kidney disease xxxx May 21,

Nimrit Goraya, MD Reference List

Nimrit Goraya, MD Reference List Book Chapter Goraya N, Wesson DE: Chapter Title The Physiology of the Metabolic Acidosis of Chronic Kidney Disease (CKD). Book title Metabolic Acidosis: A Guide to Clinical Assessment and Management 2016